✓Sep 2 session - Last update: Sep 2, 2026, 4:51 PM ET
⚡Material / Earnings✓High confidence
Source: daily_prices:fmp_change_percent
Changes History →Market closed · Next open: Thursday 9:30 AM ET
Last update: Sep 2, 2026, 6:10 PM ETMarket closed·130 changes confirmed today
Track the stock moves that actually matter.
BestStocks detects meaningful changes across price, volume, earnings, filings, valuation, analyst revisions, and risk signals — and shows you the evidence behind each one.
1,000 equities monitored14 signal typesCross-checked against SEC EDGARMedian detection lag ~41s
Investment research built around change detection.
Showing:
BestStocks identifies what changed across companies and sectors, explains why it matters, and helps investors spot opportunities worth investigating.
✓Sep 2 session - Last update: Sep 2, 2026, 4:50 PM ET
⚡Material / Earnings✓High confidence
What changed: The Trade Desk, Inc. (TTD) moved +6.59% from $13.65 to $14.55 on 2026-09-02. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume remained near its 5-day average at 1.2x.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
TTD earnings announcement on 2026-11-05 (consensus EPS estimate: $0.29).
✓Sep 2 session - Last update: Sep 2, 2026, 4:49 PM ET
⚡Material / Earnings✓High confidence
What changed: Bruker Corporation (BRKR) moved +5.34% from $56.03 to $59.02 on September 2, 2026, following a 3.4% decline the prior day that had pushed the stock roughly 7.1% below its calculated fair value of $60.28. The rebound was supported by institutional buying: Legal & General Group Plc established a new position, purchasing 145,259 shares valued at approximately $8.74 million, according to a recent SEC 13F filing.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
BRKR earnings scheduled for November 2, 2026; consensus EPS estimate is $0.42.
✓Sep 2 session - Last update: Sep 2, 2026, 4:48 PM ET
⚡Material / Earnings✓High confidence
What changed: Cipher Mining Inc. (CIFR) moved +6.14% from $14.30 to $15.18 on September 2, 2026. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume traded near its 5-day average, suggesting the move was not accompanied by unusual buying pressure.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
Monitor for confirmation of the November 2, 2026 earnings date and any catalyst that emerges before then.
✓Sep 2 session - Last update: Sep 2, 2026, 4:46 PM ET
⚡Material / Earnings✓High confidence
What changed: Hut 8 Corp. (HUT) moved +5.17% from $76.72 to $80.68 on September 2, 2026, after reports confirmed that the company is a major beneficiary of a $35 billion artificial intelligence cloud-computing deal between Anthropic and Lambda. Lambda will deploy high-end Nvidia chips into data centers managed by Hut 8 in Nueces County, Texas, solidifying the company's transition from cryptocurrency mining into AI infrastructure.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
Hut 8's earnings announcement scheduled for November 3, 2026 (consensus EPS estimate: −$0.88) will be key to confirming whether the Anthropic–Lambda partnership drives near-term profitability.
✓Sep 2 session - Last update: Sep 2, 2026, 5:08 PM ET
⚡Material / Earnings✓High confidence
What changed: Mohawk Industries, Inc. (MHK) moved +3.40% from $124.97 to $129.22 on September 2, 2026. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume remained near its 5-day average at 1.3x.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
Mohawk Industries earnings release on 2026-10-22.
✓Sep 2 session - Last update: Sep 2, 2026, 5:08 PM ET
⚡Material / Earnings✓High confidence
What changed: Zillow Group, Inc. Class A (ZG) moved +3.14% from $34.36 to $35.44 on 2026-09-02. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. The move occurred on volume near its 5-day average.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
Zillow Group earnings report expected 2026-10-29; consensus EPS estimate is $0.64.
✓Sep 2 session - Last update: Sep 2, 2026, 5:08 PM ET
⚡Material / Earnings✓High confidence
What changed: Elanco Animal Health Incorporated (ELAN) moved +2.96% from $23.97 to $24.68 on September 2, 2026. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. The move occurred on modestly elevated volume (1.5x the 5-day average).
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
Monitor for news or earnings updates ahead of the November 4 earnings announcement.
✓Sep 2 session - Last update: Sep 2, 2026, 4:52 PM ET
⚡Material / Earnings✓High confidence
What changed: Flagstar Financial, Inc. (FLG) moved +2.51% from $13.16 to $13.49 on 2026-09-02. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume was near its 5-day average, suggesting routine trading.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
Flagstar Financial's earnings announcement on 2026-10-23 against the $0.10 consensus EPS estimate.
✓Sep 2 session - Last update: Sep 2, 2026, 4:52 PM ET
🛡Material / Earnings✓High confidence
What changed: CG Oncology Inc. (CGON) moved -2.93% from $76.84 to $74.59 on 2026-09-02. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume remained near its 5-day average, indicating no unusual trading activity.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
Monitor for CGON's earnings announcement on 2026-11-13 to assess whether the company narrows losses or provides clinical/operational updates.
✓Sep 2 session - Last update: Sep 2, 2026, 4:52 PM ET
🛡Material / Earnings✓High confidence
What changed: ServiceTitan, Inc. (TTAN) moved -3.03% from $95.05 to $92.17 on 2026-09-02. We checked news, earnings announcements, analyst updates, filings, and corporate actions — no company-specific catalyst was found. Volume traded near its 5-day average, suggesting the move occurred on routine trading flow.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
ServiceTitan earnings report on 2026-09-03 and actual EPS result versus the $0.35 consensus estimate.
✓Sep 2 session - Last update: Sep 2, 2026, 4:52 PM ET
⚡Material / Earnings✓High confidence
What changed: Sensata Technologies Holding plc (ST) moved +2.90% from $40.85 to $42.04 on 2026-09-02. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume was 1.4x the 5-day average, modestly elevated.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
Monitor the 2026-10-27 earnings announcement for results against the $0.97 consensus estimate.
Latest research
View all research →In-depth equity research from the BestStocks desk — earnings breakdowns, valuation deep dives, and sector analysis behind the changes we detect.
TechnologySeptember 1, 2026 · 8 min read
Apple (AAPL) Rises as Ternus Takes Over and the Sept. 9 iPhone Event Nears
Apple rose about 2.5% to roughly $325 on September 1, and the striking part was the company it kept: on a risk-off day driven by rising Treasury yields, Apple was one of the very few large-caps to rise — Meta also gained — while Microsoft, Nvidia and Alphabet slipped alongside the Nasdaq-100. The day carried two milestones. A long-planned leadership handover took effect: John Ternus, the hardware engineer behind the iPhone and Vision Pro, became CEO, with Tim Cook — chief executive since 2011 — moving to executive chairman; the succession was announced back in April, so this was the orderly handover, not fresh news. And Apple's September 9 event, expected to unveil the iPhone 18 Pro and a first foldable, is days away. The catch is valuation: at about 36 times earnings, after a ~40% run, the stock sits right at its average analyst target and about 6% below its late-July record — and the Street is split, with a Bernstein $370 bull case against a rare Jefferies bearish call (an Underperform near $264).
AAPLRead →
IndustrialsSeptember 1, 2026 · 8 min read
Deere (DE) Hits a Record High After a Baird Upgrade on a 2027 Ag Recovery
Deere rose about 2.6% to a record high near $676 on September 1, standing out on a day technology and semiconductors sold off. The catalyst was dated and company-specific: a day earlier, Baird's Mircea Dobre upgraded Deere to Outperform and raised his price target to $800 from $640, arguing North American crop economics improve in 2027 — corn back above breakeven, better soybean margins, tighter stocks-to-use. Baird upgraded AGCO the same day, and both farm-equipment makers rose while construction bellwether Caterpillar fell, isolating an agriculture-specific move rather than a broad machinery rally. The puzzle is the valuation: Deere trades at about 36 times trailing earnings, but that reflects an expected fiscal-2026 revenue trough (down ~10% on consensus estimates), with fiscal-2027 modeled up ~8% — the recovery the upgrade is betting on. The catch: after a ~40% run to a record, the Street is split, with 11 of 24 analysts at Hold and an average target just below the price.
DERead →
HealthcareSeptember 1, 2026 · 11 min read
McKesson (MCK) Rises as a Defensive Bid Meets a $2.25B Precision Medicine Deal
McKesson rose about 2.5% to near $907 (in the upper part of its 52-week range) on September 1, standing out as technology and semiconductors sold off. The move came amid a rotation away from technology and rate-sensitive growth, as defensive areas outperformed: with the Nasdaq-100 down more than 1%, low-beta healthcare gained, and the drug distributors were among the winners — Cardinal Health and Cencora also rose. McKesson had its own tailwinds, too. On August 25 it agreed to acquire Precision Medicine Group for about $2.25 billion, folding a clinical-research and commercialization business into its fast-growing Oncology & Multispecialty segment, and it paired that with a raised outlook and a 15% dividend increase — markers of a deliberate pivot from thin-margin drug distribution into higher-value oncology and specialty services. Even so, the stock trades at about 19 times forward earnings after growing EPS more than 50% over the past year. The catch: after a ~32% run, McKesson sits near the ~$987 average analyst target, so the valuation upside has narrowed. It is a high-quality, defensively-tilted compounder the market has already discovered.
MCKRead →
ConsumerAugust 31, 2026 · 10 min read
Burlington (BURL) Stock Falls ~5% as Q3 Outlook Overshadows Q2 Beat
Burlington Stores fell about 4.8% to around $259.76 intraday on August 31, its third straight decline since the August 27 fiscal Q2 report (down ~7.6% on the 27th and ~5.9% on the 28th). The headline looked strong — reported adjusted EPS of $2.96, roughly 35% above consensus, with margin expansion and a 15th straight quarter of double-digit EPS growth — but the market looked past it. Comparable-store sales grew just 2% (down from 5% a year earlier), revenue narrowly missed at ~$3.00 billion, and Burlington guided third-quarter margins and EPS lower as it reinvests a $55 million tariff refund into customer prices. That refund also flattered the headline beat: Burlington's cleaner adjusted EPS ex-refund was $2.37 (still +38% year over year). Even though it raised full-year EPS guidance to $11.77–$11.97, a stock at ~23x earnings could not sustain a 2% comp and softer near-term margins, and Monday's leg down came as Goldman Sachs and Deutsche Bank cut targets. The move was company-specific: off-price peers Ross Stores and TJX fell less than 1% the same day. The stock is now deeply oversold (down ~31% from its high), yet 18 analysts keep a Buy consensus and a ~$365 average target.
BURLRead →
HealthcareAugust 31, 2026 · 11 min read
Cytokinetics (CYTK) Stock Falls Despite a Positive Phase 3 Aficamten Win
Cytokinetics fell about 7.5% on Friday and another ~3% Monday (to roughly $70) even though its pivotal Phase 3 ACACIA-HCM trial of aficamten met its goals in non-obstructive hypertrophic cardiomyopathy. The full data, presented at the ESC 2026 congress, hit both primary endpoints (symptoms and exercise capacity) — but the positive topline had been known since May, the stock had nearly doubled over the year, and the details disappointed: a modest effect size, two secondary endpoints that missed significance, and reduced ejection fraction (below-50% in ~10.5% of patients versus 0.8%; a known, reversible class effect). With a supplemental FDA filing not due until Q4 2026, revenue is years off, so investors sold. CYTK underperformed a soft biotech tape. Still, the Street stayed bullish: across 22 analysts, 20 rate CYTK a buy-equivalent, with an average target near $110 (about 57% above the price). Aficamten, already sold as Myqorzo for obstructive HCM, would expand into a large new patient group if the data carries through — the debate is about the details and the timeline, not whether the drug works.
CYTKRead →
TechnologyAugust 31, 2026 · 10 min read
Pinterest (PINS) Stock Falls 6% After CFO Julia Donnelly Resigns
Pinterest fell about 6% to around $21.73 on August 31 after disclosing that CFO Julia Brau Donnelly is resigning to join a private, early-stage company. She will stay until October 30 for an orderly transition, with a finance executive named interim CFO and an external search underway; the company said the exit is not due to any disagreement. Still, losing a CFO whose tenure the CEO credited with 11 straight quarters of double-digit revenue growth rattled a stock already down ~41% over the past year and trading at just ~11x forward earnings. The move was company-specific: the same day, ad peers Snap and The Trade Desk actually rose, while Meta and Alphabet fell only modestly. Analysts are constructive but split — a Buy consensus with a ~$29 average target, yet a cluster of Holds near the price — leaving the CFO exit to reopen, rather than settle, the debate over whether Pinterest's growth story holds.
PINSRead →